Characteristics | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
HR | 95%CI | P value | HR | 95%CI | P value | |
Age (years) | Â | Â | 0.299 | Â | Â | Â |
  ≤ 16 | 1.000 | Reference |  |  |  |  |
  > 16 | 1.358 | 0.762–2.420 |  |  |  |  |
Gender | Â | Â | 0.910 | Â | Â | Â |
 Male | 1.000 | Reference |  |  |  |  |
 Female | 0.983 | 0.734–1.317 |  |  |  |  |
Tumor size (cm) | Â | Â | 0.017 | Â | Â | 0.349 |
  ≤ 5 | 1.000 | Reference |  | 1.000 | Reference |  |
  > 5 | 2.006 | 1.130–3.563 |  | 1.408 | 0.688–2.883 |  |
Tumor site | Â | Â | 0.946 | Â | Â | Â |
 Extremities | 1.000 | Reference |  |  |  |  |
 Non-extremities | 0.979 | 0.525–1.824 |  |  |  |  |
Histological type | Â | Â | 0.415 | Â | Â | Â |
 Well-differentiated | 1.000 | Reference |  |  |  |  |
 Poorly differentiated | 1.272 | 0.714–2.266 |  |  |  |  |
Enneking stage |  |  |  < 0.001 |  |  | 0.007 |
 I/II | 1.000 | Reference |  | 1.000 | Reference |  |
 III | 5.695 | 2.910–11.147 |  | 3.213 | 1.373–7.520 |  |
Pathological fracture |  |  |  < 0.001 |  |  | 0.162 |
 Yes | 1.000 | Reference |  | 1.000 | Reference |  |
 No | 0.267 | 0.144–0.494 |  | 0.589 | 0.281–1.236 |  |
Neoadjuvant chemotherapy | Â | Â | 0.329 | Â | Â | Â |
 Yes | 1.000 | Reference |  |  |  |  |
 No | 1.331 | 0.749–2.365 |  |  |  |  |
Local recurrence | Â | Â | 0.001 | Â | Â | 0.029 |
 Yes | 1.000 | Reference |  | 1.000 | Reference |  |
 No | 0.384 | 0.213–0.693 |  | 0.420 | 0.193–0.917 |  |
Metastasis |  |  |  < 0.001 |  |  |  < 0.001 |
 Yes | 1.000 | Reference |  | 1.000 | Reference |  |
 No | 0.286 | 0.158–0.516 |  | 0.252 | 0.123–0.518 |  |
PAR |  |  |  < 0.001 |  |  | 0.033 |
 High | 1.000 | Reference |  | 1.000 | Reference |  |
 Low | 0.274 | 0.141–0.533 |  | 0.428 | 0.196–0.934 |  |
PLR | Â | Â | 0.019 | Â | Â | 0.438 |
 High | 1.000 | Reference |  | 1.000 | Reference |  |
 Low | 0.494 | 0.274–0.892 |  | 0.766 | 0.390–1.504 |  |
LDL-C/HDL-C | Â | Â | 0.033 | Â | Â | 0.115 |
 High | 1.000 | Reference |  | 1.000 | Reference |  |
 Low | 0.535 | 0.302–0.950 |  | 0.572 | 0.285–1.145 |  |
ApoB/ApoA1 |  |  |  < 0.001 |  |  | 0.001 |
 High | 1.000 | Reference |  | 1.000 | Reference |  |
 Low | 0.336 | 0.186–0.606 |  | 0.268 | 0.135–0.530 |  |